To use this feature, join Babbler easily !
Babbler allows PR people and reporters to collaborate a better way.
By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.
Their newsrooms are already on Babbler
You're 1 click away from signing up
Nice to see you again !
Sanofi at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
minutes reading time
minute reading time
SANOFI’S COMMITMENT AND CONTRIBUTION TO ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES (ATTD) 2020
We are proud to reinforce our commitment for advancing innovation in diabetes at this year’s ATTD, with more than 10 scientific contributions to the program.
Sanofi’s engagement at ATTD illustrates our comprehensive approach to creating a connected ecosystem that aims to help improve day-to-day diabetes management and furthers individualization of care. Our vision is to enable every individual using insulins to better manage their diabetes, underpinned by technology, medicines and education initiatives that improve health outcomes.
We are delighted to announce that we will be holding a symposium outlining this approach in more detail. In addition, we are presenting new evidence from across our diabetes portfolio. Highlights include:
Congratulations, you're registered on Babbler!
Discover now all the news waiting for you on Babbler: visit your newsfeed.!
Your topics have been selected, you can change it by clicking here